对宫颈癌移位卵巢位点的初步研究  被引量:2

Preliminary Study on Sites of Transposed Ovary in Cervical Cancer Patients

在线阅读下载全文

作  者:胡明宗 周本梅 贾钰铭[2] 雷开键[2] 徐国洪 Hu Mingzong;Zhou Benmei;Jia Yuming;Lei Kaijian;Xu Guohong(Department of Radiotherapy,The Second People’s Hospital of Yibin,Yibin 644000,Sichuan,China;Department of Oncology,The Second People’s Hospital of Yibin,Yibin 644000,Sichuan,China)

机构地区:[1]宜宾市第二人民医院放疗科,四川宜宾644000 [2]宜宾市第二人民医院肿瘤科,四川宜宾644000

出  处:《肿瘤预防与治疗》2020年第1期28-32,共5页Journal of Cancer Control And Treatment

基  金:宜宾市科技计划项目(编号:2014SF019)~~

摘  要:目的:初步探讨卵巢移位术的最佳移位点,为卵巢在宫颈癌盆腔放疗中的防护提供更多的理论依据。方法:在Elekta Xio计划系统中,分别对仿真体模和宫颈癌患者模拟四野均等、四野非均等、前后两野对穿、左右两野对穿等照射,评估各位点的吸收剂量。结果:各位点的吸收剂量随着卵巢移位高度的增加而显著降低(P<0.01),髂嵴上3cm层面各位点的吸收剂量为(2.94±1.12)Gy,略小于3Gy(P>0.05),髂嵴上4.5cm以上层面各位点的吸收剂量为(1.70±0.22)Gy,明显小于3Gy(P<0.01)。并且两个高度层面的侧方位点的剂量均低于后方。结论:对于接受盆腔盒式放疗的宫颈癌患者,建议在允许范围内将卵巢至少移至髂嵴上3~4.5cm层面,并固定于结肠旁沟靠近侧方的区域,以此减少移位卵巢的吸收剂量。Objective:To initially explore the optimal transposed site of ovarian transposition,and provide more theoreti-cal basis for ovarian protection in pelvic radiotherapy for cervical cancer.Methods:In the Elekta Xio treatment planning sys-tem,equal four-field irradiation,unequal four-field irradiation and two parallel opposed fields irradiation were simulated for humanoid phantoms and cervical cancer patients.The absorbed dose at each point was assessed.Results:As the height of o-varian movement increased,the dose in each site decreased significantly(P<0.01).The absorbed dose of each point on the layer 3cm above the iliac crest was(2.94±1.12)Gy,slightly less than 3Gy(P>0.05),and the absorbed dose of each point on the layer 4.5cm above the iliac crest was(1.70±0.22)Gy which was significantly less than 3Gy(P<0.01).Simultaneous-ly,the dose in side of the two layers was less than that in the rear of these two layers.Conclusion:For cervical cancer pa-tients undergoing pelvic radiotherapy,it is recommended to transpose the ovary to at least 3-4.5 cm above the iliac crest and fix it to the area near the side of paracolic sillcus,thus reducing the transposed ovarian dose.

关 键 词:宫颈癌 卵巢移位术 盆腔放疗 吸收剂量 

分 类 号:R730.55[医药卫生—肿瘤] R737.33[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象